Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 102

Results For "science"

1849 News Found

Zydus receives final approval from the USFDA for Diclofenac Sodium and Misoprostol Delayed Release Tablets
Drug Approval | June 14, 2023

Zydus receives final approval from the USFDA for Diclofenac Sodium and Misoprostol Delayed Release Tablets

Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg had annual sales of USD 13 mn in the United States


Ampath expands its footprint in Andhra Pradesh
Healthcare | June 14, 2023

Ampath expands its footprint in Andhra Pradesh

Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests


Merck gets favourable verdict in patent infringement lawsuit related to Bridion
News | June 14, 2023

Merck gets favourable verdict in patent infringement lawsuit related to Bridion

Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.


Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in NAFLD patients with comorbidities
Diagnostic Center | June 10, 2023

Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in NAFLD patients with comorbidities

The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52


Health Ministry organizes webinar on Non-Alcoholic Fatty Liver Diseases
News | June 09, 2023

Health Ministry organizes webinar on Non-Alcoholic Fatty Liver Diseases

Health Secretary highlights the need for capacity building programmes for Medical Officers to tackle Non Communicable Diseases at the primary level


Zydus receives final approval from USFDA for Esomeprazole Magnesium
Drug Approval | June 09, 2023

Zydus receives final approval from USFDA for Esomeprazole Magnesium

Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg had annual sales of USD 42 mn in the United States (IQVIA MAT April 2023)


Croda breaks ground on lipid manufacturing facility in Pennsylvania
News | June 09, 2023

Croda breaks ground on lipid manufacturing facility in Pennsylvania

Construction will begin this year with the new capacity anticipated by 2025


Zydus receives final approval from the USFDA for Tadalafil Tablets USP
Drug Approval | June 08, 2023

Zydus receives final approval from the USFDA for Tadalafil Tablets USP

Tadalafil Tablets USP, 20 mg had annual sales of USD 61 mn in the United States (IQVIA MAT April 2023)


BASF and Merck KGaA introduce a new standard for electronic exchange of quality and regulatory data
News | June 07, 2023

BASF and Merck KGaA introduce a new standard for electronic exchange of quality and regulatory data

The collaboration focuses on the development and sharing of Standard Quality and Regulatory Documentation (StaQRD), a standard guide for the electronic transfer of information


Piramal Critical Care appoints Jeffrey Hampton as President & COO
People | June 07, 2023

Piramal Critical Care appoints Jeffrey Hampton as President & COO

Hampton joins PCC from Accord Healthcare, where he was the President and responsible for accelerating the firm's growth strategy